Oculis Shares Are Trading Higher After the Company Announced It Expanded Its DIAMOND Program With Global Retina Experts and Is Accelerating Its Phase 3 Trials for DME Treatment.
Oculis Shares Are Trading Higher After the Company Announced It Expanded Its DIAMOND Program With Global Retina Experts and Is Accelerating Its Phase 3 Trials for DME Treatment.
Oculis股票交易走高，因该公司宣布扩大其金刚石项目，与全球视网膜专家合作，并加快进行DME治疗的3期试验。
Oculis Shares Are Trading Higher After the Company Announced It Expanded Its DIAMOND Program With Global Retina Experts and Is Accelerating Its Phase 3 Trials for DME Treatment.
Oculis宣布扩大与全球视网膜专家合作的DIAMOND计划，并正在加快其DME治疗的3期试验，此后，Oculis股价走高。
资讯热榜
更新时间